Fatty liver and lipotoxicity - PubMed (original) (raw)
Review
. 2010 Mar;1801(3):299-310.
doi: 10.1016/j.bbalip.2009.10.007. Epub 2009 Oct 24.
Affiliations
- PMID: 19857603
- DOI: 10.1016/j.bbalip.2009.10.007
Review
Fatty liver and lipotoxicity
Michael Trauner et al. Biochim Biophys Acta. 2010 Mar.
Abstract
Fatty liver disease comprises a spectrum ranging from simple steatosis to steatohepatitis which can progress to liver cirrhosis and hepatocellular cancer. Hepatic lipotoxicity may ensue when the hepatic capacity to utilize, store and export fatty acids (FA) as triglycerides is overwhelmed. Additional mechanisms of hepatic lipotoxicity include abnormal FA oxidation with formation of reactive oxygen species, disturbances in cellular membrane FA and phospholipid composition, alterations of cholesterol content and ceramide signalling. Lipotoxicity is a key factor for the progression of fatty liver disease by inducing hepatocellular death, activating Kupffer cells and an inflammatory response, impairing hepatic insulin signalling resulting in insulin resistance, and activation of a fibrogenic response in hepatic stellate cells that can ultimately lead to cirrhosis. Therefore, the concept of hepatic lipotoxicity should be considered in future therapeutic concepts for fatty liver disease.
Copyright (c) 2009 Elsevier B.V. All rights reserved.
Similar articles
- Mechanisms of disease progression in nonalcoholic fatty liver disease.
Jou J, Choi SS, Diehl AM. Jou J, et al. Semin Liver Dis. 2008 Nov;28(4):370-9. doi: 10.1055/s-0028-1091981. Epub 2008 Oct 27. Semin Liver Dis. 2008. PMID: 18956293 Review. - [Patomechanisms of hepatic steatosis].
Fülöp P, Paragh G. Fülöp P, et al. Orv Hetil. 2010 Feb 28;151(9):323-9. doi: 10.1556/OH.2010.28816. Orv Hetil. 2010. PMID: 20159747 Review. Hungarian. - Molecular mechanisms of steatosis in nonalcoholic fatty liver disease.
Pettinelli P, Obregón AM, Videla LA. Pettinelli P, et al. Nutr Hosp. 2011 May-Jun;26(3):441-50. doi: 10.1590/S0212-16112011000300003. Nutr Hosp. 2011. PMID: 21892559 Review. - Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N. Malloy VL, et al. Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5. Metabolism. 2013. PMID: 23928105 - Hepatic triglyceride synthesis and nonalcoholic fatty liver disease.
Choi SS, Diehl AM. Choi SS, et al. Curr Opin Lipidol. 2008 Jun;19(3):295-300. doi: 10.1097/MOL.0b013e3282ff5e55. Curr Opin Lipidol. 2008. PMID: 18460922 Review.
Cited by
- Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis.
Starmann J, Fälth M, Spindelböck W, Lanz KL, Lackner C, Zatloukal K, Trauner M, Sültmann H. Starmann J, et al. PLoS One. 2012;7(10):e46584. doi: 10.1371/journal.pone.0046584. Epub 2012 Oct 10. PLoS One. 2012. PMID: 23071592 Free PMC article. - Differences between adiposity indicators for predicting all-cause mortality in a representative sample of United States non-elderly adults.
Kahn HS, Bullard KM, Barker LE, Imperatore G. Kahn HS, et al. PLoS One. 2012;7(11):e50428. doi: 10.1371/journal.pone.0050428. Epub 2012 Nov 30. PLoS One. 2012. PMID: 23226283 Free PMC article. - Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models.
Chiappini F, Desterke C, Bertrand-Michel J, Guettier C, Le Naour F. Chiappini F, et al. Sci Rep. 2016 Aug 11;6:31587. doi: 10.1038/srep31587. Sci Rep. 2016. PMID: 27510159 Free PMC article. - Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells.
Albracht-Schulte K, Gonzalez S, Jackson A, Wilson S, Ramalingam L, Kalupahana NS, Moustaid-Moussa N. Albracht-Schulte K, et al. Nutrients. 2019 Mar 12;11(3):599. doi: 10.3390/nu11030599. Nutrients. 2019. PMID: 30871035 Free PMC article. - A novel cystine based antioxidant attenuates oxidative stress and hepatic steatosis in diet-induced obese mice.
Sinha-Hikim I, Sinha-Hikim AP, Shen R, Kim HJ, French SW, Vaziri ND, Crum AC, Rajavashisth TB, Norris KC. Sinha-Hikim I, et al. Exp Mol Pathol. 2011 Aug;91(1):419-28. doi: 10.1016/j.yexmp.2011.04.009. Epub 2011 May 3. Exp Mol Pathol. 2011. PMID: 21570964 Free PMC article.